Free Trial
NASDAQ:SRNE

Sorrento Therapeutics (SRNE) Stock Price, News & Analysis

Sorrento Therapeutics logo
$0.0045 +0.00 (+12.50%)
As of 03:50 PM Eastern

About Sorrento Therapeutics Stock (NASDAQ:SRNE)

Advanced

Key Stats

Today's Range
$0.0035
$0.0050
50-Day Range
N/A
52-Week Range
$0.00
$0.10
Volume
117,432 shs
Average Volume
128,271 shs
Market Capitalization
$2.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sorrento Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

SRNE MarketRank™: 

Sorrento Therapeutics scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Sorrento Therapeutics.

    • Percentage of Shares Shorted

      0.64% of the outstanding shares of Sorrento Therapeutics have been sold short.
    • Short Interest Ratio / Days to Cover

      Sorrento Therapeutics has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
    • Change versus previous month

      Short interest in Sorrento Therapeutics has recently decreased by 0.06%, indicating that investor sentiment is improving.
    • Dividend Yield

      Sorrento Therapeutics does not currently pay a dividend.

    • Dividend Growth

      Sorrento Therapeutics does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      0.64% of the outstanding shares of Sorrento Therapeutics have been sold short.
    • Short Interest Ratio / Days to Cover

      Sorrento Therapeutics has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
    • Change versus previous month

      Short interest in Sorrento Therapeutics has recently decreased by 0.06%, indicating that investor sentiment is improving.
    • Search Interest

      2 people have searched for SRNE on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
    • MarketBeat Follows

      10 people have added Sorrento Therapeutics to their MarketBeat watchlist in the last 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Sorrento Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 2.60% of the stock of Sorrento Therapeutics is held by insiders.

    • Percentage Held by Institutions

      Only 0.02% of the stock of Sorrento Therapeutics is held by institutions.

    • Read more about Sorrento Therapeutics' insider trading history.
    Receive SRNE Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    SRNE Stock News Headlines

    Sorrento Therapeutics Inc (SRNE) - Investing.com
    SRNE Sorrento Therapeutics, Inc. - Seeking Alpha
    Forget AI, This Will Be the Next Big Tech Breakthrough
    After picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be the biggest paradigm shift ever. Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution. Click here to get the name of this company, completely free of charge...tc pixel
    Sorrento Therapeutics Inc (SRNE)
    Sorrento Therapeutics Inc SRNE
    See More Headlines

    SRNE Stock Analysis - Frequently Asked Questions

    Sorrento Therapeutics' stock was trading at $0.0005 on January 1st, 2025. Since then, SRNE stock has increased by 800.0% and is now trading at $0.0045.

    Shares of SRNE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Sorrento Therapeutics investors own include NIO (NIO), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Gilead Sciences (GILD), Advanced Micro Devices (AMD) and Johnson & Johnson (JNJ).

    Company Calendar

    Today
    10/08/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Biological products, except diagnostic
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:SRNE
    CIK
    850261
    Employees
    800
    Year Founded
    2006

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    $60.32 million
    Price / Sales
    0.04
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    551,280,000
    Free Float
    536,948,000
    Market Cap
    $2.48 million
    Optionable
    No Data
    Beta
    1.19

    Social Links

    Metaverse Stocks And Why You Can't Ignore Them Cover

    Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

    Get This Free Report

    This page (NASDAQ:SRNE) was last updated on 10/8/2025 by MarketBeat.com Staff
    From Our Partners